Company Overview
Snapshot
Founded in December 2016 by Gilad Almogy, Ultima Genomics operates with 201–500 employees. The company has raised over $604.22 million across two funding rounds from seven investors. In January 2024, Ultima Genomics announced a collaboration with Quest Diagnostics to scale its technology in minimal residual disease and whole genome sequencing.
Business overview
Ultima Genomics is dedicated to advancing genomic information to drive progress in biology and human health. The company's core technology is a new sequencing architecture designed to significantly reduce the cost of genomic sequencing, enabling scientists and clinicians to overcome existing trade-offs in the breadth, depth, and frequency of genomic data utilization. Ultima Genomics serves the life sciences and healthcare industries, operating within the Health Tech & Life Sciences sector, with a focus on areas like diagnostics, genetics, and biotechnology.
Strategic signal
In January 2024, Ultima Genomics announced a strategic collaboration with Quest Diagnostics to integrate and scale its sequencing technology for minimal residual disease and whole genome sequencing. This partnership signals strong commercial validation for Ultima's platform, indicating its potential to expand access to affordable genomic information in clinical settings and accelerate the adoption of its technology within the diagnostics market.
Log in to access full profile ›Company Intelligence Q&A
- What is Ultima Genomics' primary focus?
- Ultima Genomics focuses on driving the scale of genomic information to enable unprecedented advances in biology and improvements in human health through its novel sequencing architecture.
- When was Ultima Genomics founded?
- Ultima Genomics was founded in December 2016.
- What significant collaboration did Ultima Genomics announce in January 2024?
- In January 2024, Ultima Genomics collaborated with Quest Diagnostics to scale Ultima's technology in fast-growing minimal residual disease and whole-genome sequencing.
- Which investors participated in Ultima Genomics' June 2022 funding round?
- In June 2022, Ultima Genomics received funding from investors including.
- What product did Ultima Genomics launch in February 2024?
- In February 2024, Ultima Genomics launched its UG 100™ System and presented data at AGBT.